Preclinical data also indicate potential anticancer effects independent of weight loss, such as modulation of tumor cell metabolism and inflammation, as well as reprogramming of tumor-associated macrophages toward anti-tumor (M1-like) phenotypes and enhanced cytotoxic T-cell infiltration in animal models
CREDENCE The CREDENCE trial enrolled 4,401 participants with type 2 diabetes mellitus and CKD, with a mean eGFR of 56.2 mL/min/1.73 m 2 and a median urinary albumin-to-creatinine ratio (UACR) of 927 mg/g (Table 1, Fig
When McDonalds CEO Chris Kempczinski talks about losing lower-income customers to home cooking, hes describing the wrong problem
But Rodriguez, from Colorado Springs, struggled with binge eating for seven years, which caused her to gain and lose weight repeatedly
Despite growing awareness of GLP-1 medications, obesity is still often misunderstood